A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim–Sulfamethoxazole

Weng B,Zhang X,Hong W,Yan C,Gong X,Cai C
2021-01-01
Infection and Drug Resistance
Abstract:Bowen Weng, Xiaoyue Zhang, Wenchao Hong, Chongbing Yan, Xiaohui Gong, Cheng Cai Department of Neonatology, Shanghai Children’s Hospital, Shanghai Jiao Tong University, Shanghai, 200062, People’s Republic of ChinaCorrespondence: Cheng CaiDepartment of Neonatology, Shanghai Children’s Hospital, Shanghai Jiao Tong University, Shanghai, 200062, People’s Republic of ChinaTel +86 21 52976179Fax +86 21 62790494Email caicheng2004@163.comAbstract: In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a challenge in clinical anti-infection treatment. Herein, we report the case of CRKP sepsis in an extremely low-birth weight infant (ELBWI) who did not respond to meropenem and vancomycin, but was treated successfully after a 10-day antibiotic course with trimethoprim–sulfamethoxazole (TMP-SMZ). Recent research on CRKP-associated sepsis and the application of TMP-SMZ therapy in children and neonates were reviewed to offer a reference for clinical practice.Keywords: carbapenem-resistance, extremely low birth weight infant, Klebsiella pneumoniae, sepsis, trimethoprim–sulfamethoxazole
What problem does this paper attempt to address?